OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2024
(3)
2025
(1)
2023
(1)
2022
(1)
2016
(1)
2015
(1)
2009
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study.
Not available
S-EPMC11611677
|
biostudies-literature
Cite
Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.
Not available
S-EPMC3645501
|
biostudies-literature
Cite
Volumetric body composition analysis of the Cancer Genome Atlas reveals novel body composition traits and molecular markers Associated with Renal Carcinoma outcomes.
Not available
S-EPMC11541764
|
biostudies-literature
Cite
Incident mental disorders after breast cancer: A matched population-based cohort.
Not available
S-EPMC12579550
|
biostudies-literature
Cite
Deficiency of the adaptor protein SLy1 results in a natural killer cell ribosomopathy affecting tumor clearance.
Not available
S-EPMC5215235
|
biostudies-literature
Cite
T-BET and EOMES sustain mature human NK cell identity and antitumor function.
Not available
S-EPMC10313375
|
biostudies-literature
Cite
The Impact of Persistent Smoking After Surgery on Long-term Outcomes After Stage I Non-small Cell Lung Cancer Resection.
Not available
S-EPMC9248074
|
biostudies-literature
Cite
CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.
Not available
S-EPMC4822525
|
biostudies-literature
Cite
Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses.
Not available
S-EPMC10874711
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets